PEDIATRIC VACCINES MARKET ANALYSIS

Pediatric Vaccines Market, By Vaccine Type (Pneumococcal Vaccine, DTP Vaccine, Rotavirus Vaccine, MMR Vaccine, Polio Vaccine, Influenza Vaccine, Hepatitis B Vaccine, Meningococcal Vaccine, Hib Vaccine, Varicella Vaccine), By Technology (Live or Attenuated Vaccine, Inactivated or Killed Vaccine, Toxoid Vaccine, Conjugate Vaccine, Subunit Vaccine, Recombinant Vaccine), By Type (Monovalent Vaccine and Multivalent Vaccine), By Distribution Channel (Government and Private), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Mar 2023
Code : CMI1708
Pages :190
Formats :
Excel and PDF
Industry : Biotechnology

Pediatric Vaccines MarketSize and Trends

Global pediatric vaccines market is estimated to be valued at US$ 46,424.3 million in 2023 and is expected to exhibit a CAGR of 5.93% during the forecast period (2023-2030).

Figure 1. Global Pediatric Vaccines Market Share (%), By Type, 2023

Increasing regulatory approvals of vaccine candidates by key players

Increasing inorganic activities among government authorities

Increasing inorganic activities among government authorities is expected to drive the market growth over the forecast period. For instance, in August 2022, United Nations Programme on HIV/AIDS (UNAIDS), UNICEF, and the World Health Organization (WHO) entered into a global alliance to ensure that any child suffering with HIV (human immunodeficiency virus) will get proper treatment, and to prevent new infant HIV infections. The alliance has aimed to end AIDS in children by 2030.